Share
Journal Information
Issue
Vol. 43. Issue 4.Pages 389-548 (October - December 2021)
Original articles
Prospective identification of potential factors influencing stem cell mobilization and the necessity for plerixafor use in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation
Gopal Krushna Ray, Rabindra Kumar Jena, Tribikram Panda, Sudha Sethy
Hematol Transfus Cell Ther. 2021;43:402-9
Open access
Chagas disease: Performance analysis of immunodiagnostic tests anti-Trypanosoma cruzi in blood donors with inconclusive screening results
Márcia M Ferreira-Silva, Gilberto de Araújo Pereira, Virmondes Rodrigues-Júnior, Wendell SF Meira, Fernando V Basques, Dante Mário Langhi-Júnior, Marcelo Romanelli, Eufrosina S Umezawa, ... Helio Moraes-Souza
Hematol Transfus Cell Ther. 2021;43:410-6
Open access
Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
Edvan de Queiroz Crusoé, Flávia Cristina Fernandes Pimenta, Angelo Maiolino, Nelson Siqueira de Castro, Huiling Pei, Damila Trufelli, Mariana Fernandez, Luciana Barreto Herriot
Hematol Transfus Cell Ther. 2021;43:417-23
Open access
The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
Mukta Pujani, Varsha Chauhan, Kanika Singh, Samarth Rastogi, Charu Agarwal, Kamal Gera
Hematol Transfus Cell Ther. 2021;43:424-9
Open access
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis
Russell Sterrett, Amarilis Figueiredo, Ranjeeta Mallick, Natasha Kekre, Harold Atkins, Arleigh McCurdy
Hematol Transfus Cell Ther. 2021;43:437-42
Open access
Self-perception of periodontal health status among individuals with Fanconi anemia
Nicole Nichele Perdoncini, Camila Pinheiro Furquim, Carmem Maria Sales Bonfim, Geisla Mary Silva Soares, Cassius Carvalho Torres-Pereira
Hematol Transfus Cell Ther. 2021;43:453-8
Open access
Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship
Alano Martins Pedrosa, Luzia Kalyne A.M. Leal, Romélia Pinheiro G. Lemes
Hematol Transfus Cell Ther. 2021;43:468-75
Open access
Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
Sergio Rodríguez-Rodríguez, Lorena Guerrero-Torres, María José Díaz-Huízar, Alan Pomerantz, María del Pilar Ortíz-Vilchis, Roberta Demichelis-Gómez
Hematol Transfus Cell Ther. 2021;43:476-81
Open access
Survey of Maximum Blood Ordering for Surgery (MSBOS) in elective general surgery, neurosurgery and orthopedic surgery at the Poursina Hospital in Rasht, Iran, 2017
Moein Moghaddamahmadi, Hossein Khoshrang, Seyed Sepehr Khatami, Alireza Hooshmand Marvasti, Hoora Ghovvati Choshal, Simin Mehrkhah
Hematol Transfus Cell Ther. 2021;43:482-8
Open access
Duffy phenotyping and FY*B-67T/C genotyping as screening test for benign constitutional neutropenia
Maria E.S.F. Barreto, Mariana E. Lipay, Leandro D. Santos, Marilia F. Mascarenhas Sirianni, Thiago H. Costa, Lilian Castilho, Nelson Hamerschlak, José M. Kutner, Carolina B. Bub
Hematol Transfus Cell Ther. 2021;43:489-93
Open access
Special content
Special Content
Review article
Special article
Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels
Míriam P. Beltrame, Elizabeth Xisto Souto, Mihoko Yamamoto, Felipe M Furtado, Elaine Sobral da Costa, Alex Freire Sandes, Glicínia Pimenta, Geraldo Barroso Cavalcanti Júnior, ... Maura R V Ikoma-Colturato
Hematol Transfus Cell Ther. 2021;43:499-506
Open access
Case reports
Bone marrow necrosis in a patient with advanced Hodgkin's lymphoma after G-CSF and Plerixafor treatment during harvesting for autologous bone marrow transplantation: is it possible?
Najmaddin Khoshnaw, Ahmed K. Yassin, Sana J. Dlawar, Alaa F. Alwan, Parween Kh. Ismael, Hameed S.M. Saeed, Layth Mula-Hussain
Hematol Transfus Cell Ther. 2021;43:512-4
Open access
Letters to the editor
Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions
Caroline Henriques Garcia, Roberta Maria da Silva Oliveira Safranauskas, Alanna Mara P.S. Bezerra, Elvira D.R.P. Velloso
Hematol Transfus Cell Ther. 2021;43:521-6
Open access
Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
Ömer Faruk Bahçecioğlu, Selim Gök, Mefküre Durmuş, Ahmet Sarıcı
Hematol Transfus Cell Ther. 2021;43:527-8
Open access
Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series
Giancarlo Fatobene, Gabriela Rodriguez de Souza, Celso Arrais Rodrigues, Yana Augusta Sarkis Novis, Vanderson Rocha
Hematol Transfus Cell Ther. 2021;43:532-6
Open access
Special content
Special Content
Images in clinical hematology
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.